RESUMO
Although infections caused by megalocytiviruses have been reported from a wide range of finfish species for several decades, molecular characterisation of the viruses involved has been undertaken only on more recent cases. Sequence analysis of the major capsid protein and adenosine triphosphatase genes is reported here from formalin-fixed, paraffin-embedded material from 2 archival ornamental fish cases from 1986 and 1988 in conjunction with data for a range of genes from fresh frozen tissues from 5 cases obtained from 1991 through to 2010. Turbot reddish body iridovirus (TRBIV) genotype megalocytiviruses, previously not documented in ornamental fish, were detected in samples from 1986, 1988 and 1991. In contrast, megalocytiviruses from 1996 onwards, including those characterised from 2002, 2006 and 2010 in this study, were almost indistinguishable from infectious spleen and kidney necrosis virus (ISKNV). Three of the species infected with TRBIV-like megalocytiviruses from 1986 to 1991, viz. dwarf gourami Trichogaster lalius (formerly Colisa lalia), freshwater angelfish Pterophyllum scalare and oscar Astronotus ocellatus, were infected with ISKNV genotype megalocytiviruses from 2002 to 2010. The detection of a TRBIV genotype isolate in ornamental fish from 1986 represents the index case, confirmed by molecular sequence data, for the genus Megalocytivirus.
Assuntos
Peixes/virologia , Iridoviridae/genética , Iridoviridae/isolamento & purificação , Animais , Bancos de Espécimes Biológicos , DNA Viral/genética , DNA Viral/isolamento & purificação , Genótipo , FilogeniaRESUMO
Crystals seldom form spontaneously within tissues of mammals, except in the urinary tract or in association with eosinophil-rich diseases in humans (Charcot-Leyden crystals). Endogenously formed eosinophilic crystals have been reported in respiratory tract and other tissues of several strains of mice, but the biochemical characterization of these crystals has not been reported. In this study, eosinophilic crystal formation was examined in homozygous C57BL/6J viable motheaten mice, lung-specific surfactant apoprotein C promoter/soluble human tumor necrosis factor p75 receptor type II fusion protein transgenic mice (C57BL/6NTac x Sv/129), and CD40L-deficient mice with spontaneous Pneumocystis carinii infection. In viable motheaten but not wild type mice, rapidly developing crystals represented a major feature of the fatal lung injury induced by macrophage dysregulation. Conversely, eosinophilic crystals did not form until 4-8 months of age in transgenic and CD40L-deficient mice and were present in 10-30% of age-matched wild type controls. Mass spectrometry analysis of proteins from bronchoalveolar lavage fluid identified the crystals as Ym1, sometimes referred to as T-lymphocyte-derived eosinophil chemotactic factor. The Ym1 sequence was homologous to chitinase, and enzymatic assays indicated a 3-5-fold increase in chitinase activity compared with control mice. Intracellular and extracellular crystals associated with epithelial damage suggested that the crystals may contribute to lung inflammation through mechanical damage and enzymatic degradation.
Assuntos
Quimiocinas C , Fatores Quimiotáticos de Eosinófilos/isolamento & purificação , Eosinófilos/química , Glicoproteínas/isolamento & purificação , Pulmão/química , Linfocinas/isolamento & purificação , Proteínas Tirosina Fosfatases/genética , Sialoglicoproteínas/isolamento & purificação , Sequência de Aminoácidos , Animais , Antígenos CD/genética , Apoproteínas/genética , Líquido da Lavagem Broncoalveolar/química , Ligante de CD40 , Quitinases/análise , Cristalização , Eosinófilos/patologia , Humanos , Peptídeos e Proteínas de Sinalização Intracelular , Pulmão/patologia , Lisofosfolipase , Espectrometria de Massas , Glicoproteínas de Membrana/genética , Camundongos , Camundongos Transgênicos , Dados de Sequência Molecular , Fragmentos de Peptídeos/química , Proteína Tirosina Fosfatase não Receptora Tipo 6 , Proteolipídeos/genética , Surfactantes Pulmonares/genética , Receptores do Fator de Necrose Tumoral/genética , Receptores Tipo II do Fator de Necrose Tumoral , Análise de Sequência de ProteínaRESUMO
C57BL/6 mice genetically deficient in interleukin 15 (IL-15(-/-) mice) were generated by gene targeting. IL-15(-/-) mice displayed marked reductions in numbers of thymic and peripheral natural killer (NK) T cells, memory phenotype CD8(+) T cells, and distinct subpopulations of intestinal intraepithelial lymphocytes (IELs). The reduction but not absence of these populations in IL-15(-/-) mice likely reflects an important role for IL-15 for expansion and/or survival of these cells. IL-15(-/-) mice lacked NK cells, as assessed by both immunophenotyping and functional criteria, indicating an obligate role for IL-15 in the development and functional maturation of NK cells. Specific defects associated with IL-15 deficiency were reversed by in vivo administration of exogenous IL-15. Despite their immunological defects, IL-15(-/-) mice remained healthy when maintained under specific pathogen-free conditions. However, IL-15(-/-) mice are likely to have compromised host defense responses to various pathogens, as they were unable to mount a protective response to challenge with vaccinia virus. These data reveal critical roles for IL-15 in the development of specific lymphoid lineages. Moreover, the ability to rescue lymphoid defects in IL-15(-/-) mice by IL-15 administration represents a powerful means by which to further elucidate the biological roles of this cytokine.
Assuntos
Linfócitos T CD8-Positivos/imunologia , Memória Imunológica , Interleucina-15/imunologia , Células Matadoras Naturais/imunologia , Receptores de Interleucina-2/imunologia , Animais , Linhagem da Célula , Células Epiteliais/imunologia , Feminino , Interleucina-15/genética , Linfonodos/anatomia & histologia , Linfonodos/imunologia , Contagem de Linfócitos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Mutantes , Tamanho do Órgão , Receptores de Interleucina-15 , Receptores de Interleucina-2/genética , Baço/anatomia & histologia , Baço/imunologia , Timo/anatomia & histologia , Timo/imunologia , Vacínia/mortalidadeRESUMO
Several colony stimulating factors (CSFs) and cytokines have been successfully used to mobilize hematopoietic cells during myeloablative therapy, bone marrow failure, and transplantation and to provide supportive treatment during sepsis. The use of yeast-derived recombinant human granulocyte-macrophage CSF (rhuGM-CSF) and its interleukin-3 fusion protein, PIXY321, provides an example of issues associated with development programs for recombinant hematopoietic growth factors. Species specificity of rhuGM-CSF, different bioactivity of homologous molecules in mice, and production in laboratory animals of antibodies to human proteins limit preclinical evaluation of such molecules. In clinical trials, rhuGM-CSF was efficacious and well tolerated. The derivation of the recombinant molecule, optimal dosing, scheduling, and confounding effects of concurrent disease and treatments are factors that influence efficacy, adverse responses, and immunogenicity reported in patients treated with CSFs. In comparisons of yeast-derived with Escherichia coli-derived rhuGM-CS, the reduced severity and frequency of all adverse events, preponderance of low-grade adverse events, and similarity of positive clinical response versus adverse events reported for granulocyte CSF support safety and efficacy of yeast-derived rhuGM-CSE Enhanced pharmacoeconomic evaluations are beginning to limit and redirect clinical applications in this class of biological agents.
Assuntos
Fator Estimulador de Colônias de Granulócitos e Macrófagos/biossíntese , Fator Estimulador de Colônias de Granulócitos e Macrófagos/farmacologia , Proteínas Recombinantes de Fusão/biossíntese , Proteínas Recombinantes de Fusão/farmacologia , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/farmacologia , Animais , Ensaios Clínicos como Assunto , Desenho de Fármacos , Avaliação Pré-Clínica de Medicamentos , Fator Estimulador de Colônias de Granulócitos e Macrófagos/uso terapêutico , Humanos , Proteínas Recombinantes de Fusão/uso terapêutico , Proteínas Recombinantes/uso terapêuticoRESUMO
Rapid advances in our ability to localize and quantify macromolecular changes in health and disease are being brought about by the availability of genetically altered animals (mutants), purified reagents such as monoclonal antibodies, and new molecular methods. Targeted gene deletion (knockouts) and gene insertions (transgenics) in animals can allow identification of the importance and function of macromolecules. Monoclonal antibodies and fluorescent labels coupled with advances in microscopy provide exacting and multi-dimensional information about localization and cellular changes in proteins, carbohydrates, and lipids using immunohistochemistry, fluorescent activated cell sorting, and immunoprecipitation. Similarly, new applications of molecular methods can be used to identify and localize nucleic acids in tissues via in situ hybridization, polymerase chain reaction (PCR), reverse transcription (RT) PCR, differential display RT-PCR, RNase protection assays, and microchip arrays. The ligand for CD40 (CD40L), an important immunoregulatory molecule, is an example of the successful application of mutants, monoclonal antibodies, and molecular methods to cloning and biological characterization of new molecules. CD40L knockout mice, monoclonal antibodies, and several molecular methods were used to identify mutations in CD40L as the genetic basis for hyper-IgM syndrome in humans, to provide new insights into the pathobiology of Pneumocystis carinii infection, and to evaluate CD40L for immunotherapy of tumors and opportunistic infections.
Assuntos
Anticorpos Monoclonais , Técnicas Genéticas , Mutação , Patologia/métodos , Animais , Modelos Animais de Doenças , Engenharia Genética/métodos , HumanosRESUMO
To evaluate the utility of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as a cancer therapeutic, we created leucine zipper (LZ) forms of human (hu) and murine (mu) TRAIL to promote and stabilize the formation of trimers. Both were biologically active, inducing apoptosis of both human and murine target cells in vitro with similar specific activities. In contrast to the fulminant hepatotoxicity of LZ-huCD95L in vivo, administration of either LZ-huTRAIL or LZ-muTRAIL did not seem toxic to normal tissues of mice. Finally, repeated treatments with LZ-huTRAIL actively suppressed growth of the TRAIL-sensitive human mammary adenocarcinoma cell line MDA-231 in CB.17 (SCID) mice, and histologic examination of tumors from SCID mice treated with LZ-huTRAIL demonstrated clear areas of apoptotic necrosis within 9-12 hours of injection.
Assuntos
Antineoplásicos/farmacologia , Apoptose/efeitos dos fármacos , Glicoproteínas de Membrana/farmacologia , Fator de Necrose Tumoral alfa/farmacologia , Animais , Proteínas Reguladoras de Apoptose , Relação Dose-Resposta a Droga , Proteína Ligante Fas , Humanos , Glicoproteínas de Membrana/administração & dosagem , Glicoproteínas de Membrana/síntese química , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos C57BL , Camundongos SCID , Conformação Proteica , Ligante Indutor de Apoptose Relacionado a TNF , Células Tumorais Cultivadas , Fator de Necrose Tumoral alfa/administração & dosagem , Fator de Necrose Tumoral alfa/síntese químicaRESUMO
Daily treatment of mice with recombinant human Flt3 ligand (huFlt3L) results in a dramatic numerical increase in the number of dendritic cells (DCs) in vivo. Since DCs are pivotal in the induction of immune responses, we tested whether Flt3L treatment of mice challenged with a syngeneic methylcholanthrene (MCA)-induced fibrosarcoma would augment the generation of effective antitumor immune responses in vivo. Flt3L treatment not only induced complete tumor regression in a significant proportion of mice, but also decreased tumor growth rate in the remaining mice. A preliminary characterization of the cellular mechanisms involved suggests that Flt3L may be important in the treatment of cancer in situ through the generation of specific antitumor immune responses.
Assuntos
Fibrossarcoma/tratamento farmacológico , Proteínas de Membrana/uso terapêutico , Animais , Células Dendríticas/efeitos dos fármacos , Células Dendríticas/imunologia , Relação Dose-Resposta a Droga , Feminino , Fibrossarcoma/induzido quimicamente , Fibrossarcoma/imunologia , Fibrossarcoma/patologia , Imunidade Celular/efeitos dos fármacos , Metilcolantreno , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Recombinantes/uso terapêutico , Baço/imunologiaAssuntos
Neoplasias Renais/veterinária , Mesenquimoma/veterinária , Ratos Wistar , Doenças dos Roedores/patologia , Tumor de Wilms/veterinária , Animais , Feminino , Rim/patologia , Neoplasias Renais/congênito , Neoplasias Renais/patologia , Masculino , Mesenquimoma/congênito , Mesenquimoma/patologia , Ratos , Doenças dos Roedores/congênito , Tumor de Wilms/congênito , Tumor de Wilms/patologiaRESUMO
Retinoschisis, an extreme form of cystic degeneration of the retina, was identified as a diffuse, bilateral microscopical change in an 8-month-old, male, English springer spaniel dog with a clinical history of blindness, retinal detachment and glaucoma. The absence of any material in the cystic spaces and the spectrum of intraocular degenerative changes indicated that the retinal change was a secondary retinoschisis, probably due to retinal detachment. Separation of retinal layers without disruption of the blood supply probably plays a part in the aetiology of retinoschisis. The pathogenesis and natural history of intraretinal cystic changes and retinoschisis in animals are poorly understood.
Assuntos
Doenças do Cão/patologia , Degeneração Retiniana/veterinária , Descolamento Retiniano/veterinária , Animais , Doenças do Cão/etiologia , Cães , Masculino , Degeneração Retiniana/etiologia , Degeneração Retiniana/patologia , Descolamento Retiniano/complicações , Descolamento Retiniano/patologiaRESUMO
Immunoperoxidase staining and electron and light microscopy were used to characterize the development of the pharyngeal tonsil in 98 cattle aged between 30 days of gestation and 12 years. The rugae of the pharyngeal tonsil were poorly formed before 95 days of gestation. Microvillous (M) cells associated with intra-epithelial leucocytes (lympho-epithelium) were scattered among ciliated and goblet cells covering most of the surface in post-natal animals. Intra-epithelial leucocytes were rare in fetuses, but ciliated and M cells could be distinguished. Leucocytes of the lamina propria started to accumulate at approximately 120 days of gestation. A loose accumulation of mononuclear cells progressed into a B-cell rich upper and T-cell rich lower layer, with typical lymphoid tissue organization in post-natal animals and lymphoid involution in aged cattle. Primary lymphoid follicles formed at 5 months of gestation, but germinal centres did not form until 2 to 4 weeks after birth. Except for null cells, the relative number of cells staining for each leucocyte phenotype or MHC class II antigen increased with age, especially during the neonatal period. The early development, strategic location and specialized structure of the pharyngeal tonsil suggest an important role in modulating inhaled antigens in cattle. Fetal and neonatal calves had minimal lymphoid tissue priming, as indicated by lack of secondary follicles, low MHC class II expression and few intra-epithelial leucocytes. The phenotypic differences may be relevant to the increased susceptibility of calves to infectious diseases shortly after birth.
Assuntos
Bovinos/embriologia , Tonsila Palatina/embriologia , Tonsila Palatina/crescimento & desenvolvimento , Animais , Imunofenotipagem/veterinária , Microscopia Eletrônica/veterinária , Microscopia Eletrônica de Varredura/veterináriaRESUMO
The potential involvement of the pharyngeal tonsil in the pathogenesis of bovine herpesvirus-1 (BHV-1) infection was examined in neonatal and weanling calves infected by intranasal aerosol. Calves were monitored from days 1 to 5, and on day 6 (neonates) or 8 (weanlings) and, in a second trial at day 4.5, by histology, electron microscopy, immunocytochemistry and virus isolation. Mucosal lesions of neonates were similar to, but less extensive than, those of weanling calves. Loss of microvilli and goblet cells, with minimal epithelial erosions as early as day 1, progressed to necrosis of epithelium and adjacent lymphoid tissue, and leucocyte exudation. Lesions and clinical disease were progressive up to and including day 6 in neonates, but resolving in weanlings on days 5 and 8. By transmission electron microscopy, the physical characteristics of the phagocytic cells appeared similar in both age groups, and viral replication was not identified in leucocytes. Virus was isolated from, or found by immunocytochemistry in, the pharyngeal tonsil of all calves examined, except for two weanlings on days 1 and 8. Virus as detected by immunocytochemistry was restricted to epithelium and superficial lymphoid tissue in neonates, but was found in deep lymphoid tissue around germinal centres in weanlings. The study showed that the pharyngeal tonsil is readily infected with BHV-1 and may be an important lymphoid tissue for early anti-viral responses. The delayed inflammatory response and reduced viral clearance may contribute to the increased susceptibility of neonatal calves to fatal BHV-1 infections.
Assuntos
Rinotraqueíte Infecciosa Bovina/patologia , Tonsila Palatina , Animais , Animais Recém-Nascidos , Bovinos , Imuno-Histoquímica , Microscopia Eletrônica/veterinária , Microscopia Eletrônica de Varredura/veterinária , DesmameRESUMO
Four horses from the same farm developed clinical signs of botulism during the winter months; three of these horses died. One horse survived an initial attack and recovered over a three-week period, but died during a second attack. The horse that survived took six weeks to recover. Clinical and postmortem examination ruled out other causes of disease. Confirmation of the diagnosis was made by isolation of Clostridium botulinum type C toxin from the dirt in the bottom of an oak feedtrough used by all horses, and from the colonic contents of one of the horses that died. To our knowledge, this is the second case of C. botulinum type C intoxication reported in horses in North America. In both cases, soil and sand near aquatic environments were identified as the source of toxin.
RESUMO
A congenital benign intraocular melanoma was the cause of extreme buphthalmos in the enucleated right eye of a 7-day-old Charolais-cross calf. The tumour was well differentiated with rare mitotic figures and no evidence of extrascleral nor vascular invasion. Congenital intraocular tumours occur rarely in animals and man. There was no evidence of malignancy when the calf was slaughtered 9 months after the enucleation.
Assuntos
Doenças dos Bovinos/patologia , Neoplasias Oculares/veterinária , Melanoma/veterinária , Animais , Bovinos , Doenças dos Bovinos/congênito , Neoplasias Oculares/congênito , Neoplasias Oculares/patologia , Masculino , Melanoma/congênito , Melanoma/patologia , MitoseRESUMO
Bilateral true colobomas with retrobulbar cysts located over the optic nerves are described in an 8-year-old Quarterhorse mare with a history of progressive blindness. Colobomas result from the failure of an embryonic fissure to close and retrobulbar cysts result from eversion of the neuroectoderm through the colobomas. It could not be determined whether the small optic nerves and the scars, rosettes and disorganization of the cell layers in the retina were the result of concurrent dysplasia or were secondary to degeneration.
Assuntos
Coloboma/veterinária , Doenças dos Cavalos/patologia , Nervo Óptico/patologia , Retina/patologia , Animais , Cegueira/veterinária , Coloboma/patologia , Feminino , CavalosRESUMO
Forty-seven cases of neonatal vertebral fractures/luxations occurred in a 21 year period (1967-1987). All of the fractures were located between the 11th thoracic vertebra and the fourth lumbar vertebra; 77% occurred at the thoracolumbar junction. All but one case was associated with a forced extraction, either unspecified (53%), mechanical (28%), or manual (17%).A weak calf or continuous recumbency since birth was the major clinical sign. Hemorrhage around the kidneys, adrenal glands, and in perivertebral muscles was a consistent necropsy finding and a useful indicator that a thoracolumbar fracture was present. In addition to the vertebral fracture, the prominent necropsy findings were subdural and epidural hemorrhage, myelomalacia, spinal cord compression or severed spinal cord, and fractured ribs. All of the calves died or were euthanized without regaining locomotory function.